Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Th17 cell differentiation	5/107	8.875508356321046e-08	3.7720910514364444e-06	78.09803921568627	-218.72241114395115	IKBKG;IL17A;IL17F;IL22;NFKB1
KEGG_2021_Human	IL-17 signaling pathway	5/94	4.613881700165173e-08	3.7720910514364444e-06	89.65168539325843	-243.34942399375765	IKBKG;IL17A;IL17F;NFKB1;TNFAIP3
KEGG_2021_Human	Inflammatory bowel disease	4/65	7.733227471018954e-07	2.1910811167887037e-05	87.50819672131148	-195.3419859289311	IL17A;IL17F;IL22;NFKB1
KEGG_2021_Human	Taurine and hypotaurine metabolism	2/11	7.541696728957924e-05	0.0016026105549035588	223.86111111111111	-161.78418475842457	GAD1;GAD2
KEGG_2021_Human	NF-kappa B signaling pathway	3/104	0.0002329673917108638	0.003960445659084684	33.806223479490804	-67.40758155759835	IKBKG;NFKB1;TNFAIP3
KEGG_2021_Human	TNF signaling pathway	3/112	0.00029005838446074546	0.004109160446527227	31.293577981651374	-63.06696788213405	IKBKG;NFKB1;TNFAIP3
KEGG_2021_Human	Measles	3/139	0.0005476317685268026	0.005563139805791084	24.99579831932773	-51.672386684351224	IKBKG;NFKB1;TNFAIP3
KEGG_2021_Human	beta-Alanine metabolism	2/30	0.0005890383323778795	0.005563139805791084	71.78571428571429	-75.93290601172647	GAD1;GAD2
KEGG_2021_Human	Butanoate metabolism	2/28	0.0005125308961300685	0.005563139805791084	77.32692307692308	-80.15945568848299	GAD1;GAD2
KEGG_2021_Human	Alanine, aspartate and glutamate metabolism	2/37	0.0008976760152685225	0.00731711634173044	57.378571428571426	-64.24352876962546	GAD1;GAD2
KEGG_2021_Human	Primary immunodeficiency	2/38	0.0009469209383415865	0.00731711634173044	55.77777777777778	-62.87407127134141	AIRE;IKBKG
KEGG_2021_Human	Type I diabetes mellitus	2/43	0.0012123028259538784	0.007926595400467666	48.94512195121951	-56.84526782917664	GAD1;GAD2
KEGG_2021_Human	NOD-like receptor signaling pathway	3/181	0.0011822602400977265	0.007926595400467666	18.996789727126806	-40.00053498134924	IKBKG;NFKB1;TNFAIP3
KEGG_2021_Human	Epstein-Barr virus infection	3/202	0.0016236545858167558	0.009857902842458875	16.946877243359655	-35.79178563433967	IKBKG;NFKB1;TNFAIP3
KEGG_2021_Human	RIG-I-like receptor signaling pathway	2/70	0.0031848593502604382	0.014248054988007222	29.41176470588235	-37.553176952571945	IKBKG;NFKB1
KEGG_2021_Human	Adipocytokine signaling pathway	2/69	0.0030959091544989293	0.014248054988007222	29.854477611940297	-38.032897794694755	IKBKG;NFKB1
KEGG_2021_Human	Acute myeloid leukemia	2/67	0.002921615714870147	0.014248054988007222	30.78076923076923	-39.02900444511024	IKBKG;NFKB1
KEGG_2021_Human	Epithelial cell signaling in Helicobacter pylori infection	2/70	0.0031848593502604382	0.014248054988007222	29.41176470588235	-37.553176952571945	IKBKG;NFKB1
KEGG_2021_Human	Cytosolic DNA-sensing pathway	2/63	0.00258752682682323	0.014248054988007222	32.8155737704918	-41.182346051003734	IKBKG;NFKB1
KEGG_2021_Human	Chronic myeloid leukemia	2/76	0.0037436519554145367	0.015152876962392172	27.006756756756758	-34.90410589940028	IKBKG;NFKB1
KEGG_2021_Human	Pancreatic cancer	2/76	0.0037436519554145367	0.015152876962392172	27.006756756756758	-34.90410589940028	IKBKG;NFKB1
KEGG_2021_Human	B cell receptor signaling pathway	2/81	0.004241897027183041	0.016389147605025384	25.281645569620252	-32.95657984925952	IKBKG;NFKB1
KEGG_2021_Human	Cytokine-cytokine receptor interaction	3/295	0.004778958454651453	0.01712817972312679	11.412915851272016	-23.74866982495136	IL17A;IL17F;IL22
KEGG_2021_Human	GABAergic synapse	2/89	0.005099890907028776	0.01712817972312679	22.933908045977013	-30.23706529396038	GAD1;GAD2
KEGG_2021_Human	Small cell lung cancer	2/92	0.005440715912052039	0.01712817972312679	22.16111111111111	-29.32328202848766	IKBKG;NFKB1
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	2/89	0.005099890907028776	0.01712817972312679	22.933908045977013	-30.23706529396038	IKBKG;NFKB1
KEGG_2021_Human	Th1 and Th2 cell differentiation	2/92	0.005440715912052039	0.01712817972312679	22.16111111111111	-29.32328202848766	IKBKG;NFKB1
KEGG_2021_Human	Prostate cancer	2/97	0.006031622120792857	0.018310281438121172	20.981578947368423	-27.909669646620806	IKBKG;NFKB1
KEGG_2021_Human	Chagas disease	2/102	0.006650847322673755	0.018345123481066677	19.92	-26.61700675496218	IKBKG;NFKB1
KEGG_2021_Human	C-type lectin receptor signaling pathway	2/104	0.006906399428166279	0.018345123481066677	19.524509803921568	-26.130280011490946	IKBKG;NFKB1
KEGG_2021_Human	Toll-like receptor signaling pathway	2/104	0.006906399428166279	0.018345123481066677	19.524509803921568	-26.130280011490946	IKBKG;NFKB1
KEGG_2021_Human	T cell receptor signaling pathway	2/104	0.006906399428166279	0.018345123481066677	19.524509803921568	-26.130280011490946	IKBKG;NFKB1
KEGG_2021_Human	Toxoplasmosis	2/112	0.007973056255711614	0.02053666005259052	18.086363636363636	-24.33571316400054	IKBKG;NFKB1
KEGG_2021_Human	Osteoclast differentiation	2/127	0.010161324318032567	0.025403310795081416	15.886	-21.510038502238015	IKBKG;NFKB1
KEGG_2021_Human	Fluid shear stress and atherosclerosis	2/139	0.012084353093672291	0.028532500360059578	14.472627737226277	-19.639406588988233	IKBKG;NFKB1
KEGG_2021_Human	Yersinia infection	2/137	0.011753397776716717	0.028532500360059578	14.690740740740742	-19.931093924152265	IKBKG;NFKB1
KEGG_2021_Human	Apoptosis	2/142	0.012588538285001706	0.028919614979057973	14.157142857142857	-19.21549786230027	IKBKG;NFKB1
KEGG_2021_Human	Hepatitis C	2/157	0.015246968798416489	0.03410506178593162	12.762903225806452	-17.312716751580805	IKBKG;NFKB1
KEGG_2021_Human	Hepatitis B	2/162	0.016183180370760934	0.035271034141402036	12.35625	-16.748364182562245	IKBKG;NFKB1
KEGG_2021_Human	Influenza A	2/172	0.01812904275363809	0.03852421585148094	11.614705882352942	-15.707848772731996	IKBKG;NFKB1
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	2/193	0.02252556995474682	0.04558746300365427	10.31020942408377	-13.840129933766221	IKBKG;NFKB1
KEGG_2021_Human	Chemokine signaling pathway	2/192	0.0223068963273402	0.04558746300365427	10.365789473684211	-13.920708621090329	IKBKG;NFKB1
KEGG_2021_Human	Pathogenic Escherichia coli infection	2/197	0.0234094024256627	0.04627440014375185	10.093589743589744	-13.525208778126117	IKBKG;NFKB1
KEGG_2021_Human	Viral carcinogenesis	2/203	0.024762333575826773	0.047836326226028986	9.784825870646767	-13.073912909097736	IKBKG;NFKB1
KEGG_2021_Human	Human immunodeficiency virus 1 infection	2/212	0.026851997557997137	0.05072043983177237	9.354761904761904	-12.440530405951861	IKBKG;NFKB1
KEGG_2021_Human	Lipid and atherosclerosis	2/215	0.027564399546120597	0.050934216552614146	9.219483568075118	-12.240131856521	IKBKG;NFKB1
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	2/219	0.028526440921903908	0.051590371880038975	9.044930875576037	-11.980722307867735	IKBKG;NFKB1
KEGG_2021_Human	Human cytomegalovirus infection	2/225	0.029995320515188703	0.05311671341231333	8.794843049327355	-11.607417281005194	IKBKG;NFKB1
KEGG_2021_Human	Ras signaling pathway	2/232	0.03174764714886429	0.0539710001530693	8.519565217391305	-11.194266119915625	IKBKG;NFKB1
KEGG_2021_Human	Coronavirus disease	2/232	0.03174764714886429	0.0539710001530693	8.519565217391305	-11.194266119915625	IKBKG;NFKB1
KEGG_2021_Human	Shigellosis	2/246	0.035374463538784595	0.05895743923130766	8.01639344262295	-10.432967830507518	IKBKG;NFKB1
KEGG_2021_Human	Salmonella infection	2/249	0.03617242514905692	0.05912800264749689	7.915991902834008	-10.280113155611538	IKBKG;NFKB1
KEGG_2021_Human	MAPK signaling pathway	2/294	0.04897898942595734	0.07855120945672403	6.657534246575342	-8.337786615237395	IKBKG;NFKB1
KEGG_2021_Human	Cocaine addiction	1/49	0.05906133610748362	0.09296691794696496	18.564814814814813	-10.829316375605623	NFKB1
KEGG_2021_Human	Human papillomavirus infection	2/331	0.06060431633754296	0.09366121615802094	5.880699088145897	-7.115618067766183	IKBKG;NFKB1
KEGG_2021_Human	PI3K-Akt signaling pathway	2/354	0.06828569708469599	0.10200003471322855	5.480113636363637	-6.479364551821025	IKBKG;NFKB1
KEGG_2021_Human	Legionellosis	1/57	0.06840002327828267	0.10200003471322855	15.896825396825397	-9.424000900813787	NFKB1
KEGG_2021_Human	Prolactin signaling pathway	1/70	0.08339759626885078	0.12222061522159165	12.880837359098228	-7.74542097629872	NFKB1
KEGG_2021_Human	Leishmaniasis	1/77	0.09138288226635771	0.12945908321067343	11.68421052631579	-7.04872976578505	NFKB1
KEGG_2021_Human	Pertussis	1/76	0.09024597396088518	0.12945908321067343	11.841481481481482	-7.141387005986298	NFKB1
KEGG_2021_Human	Rheumatoid arthritis	1/93	0.1094003568916107	0.1524431202588018	9.632850241545894	-5.8073541800756905	IL17A
KEGG_2021_Human	Amoebiasis	1/102	0.11939326812281527	0.15856918422561403	8.764576457645765	-5.262086311101535	NFKB1
KEGG_2021_Human	Longevity regulating pathway	1/102	0.11939326812281527	0.15856918422561403	8.764576457645765	-5.262086311101535	NFKB1
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	1/100	0.11718138394436346	0.15856918422561403	8.94388327721661	-5.375723879218761	NFKB1
KEGG_2021_Human	Herpes simplex virus 1 infection	2/498	0.12295964829332588	0.16079338622973385	3.816532258064516	-3.814605004177811	IKBKG;NFKB1
KEGG_2021_Human	HIF-1 signaling pathway	1/109	0.1270956407872156	0.1612407383121392	8.189300411522634	-4.893732148578802	NFKB1
KEGG_2021_Human	Insulin resistance	1/108	0.12599902727061665	0.1612407383121392	8.2668743509865	-4.943743954376122	NFKB1
KEGG_2021_Human	Sphingolipid signaling pathway	1/119	0.13799386385009413	0.16756397753225716	7.4858757062146895	-4.435243302362896	NFKB1
KEGG_2021_Human	Pathways in cancer	2/531	0.13679480156092927	0.16756397753225716	3.5628544423440456	-3.410136075895621	IKBKG;NFKB1
KEGG_2021_Human	Neurotrophin signaling pathway	1/119	0.13799386385009413	0.16756397753225716	7.4858757062146895	-4.435243302362896	NFKB1
KEGG_2021_Human	Relaxin signaling pathway	1/129	0.1487694756391342	0.1781043018214987	6.892361111111111	-4.041189892105298	NFKB1
KEGG_2021_Human	Ubiquitin mediated proteolysis	1/140	0.16048249753809815	0.18945850403803255	6.338129496402877	-3.6670604531534	AIRE
KEGG_2021_Human	Non-alcoholic fatty liver disease	1/155	0.17622102470306392	0.20361032764753367	5.70995670995671	-3.235678410841787	NFKB1
KEGG_2021_Human	Cellular senescence	1/156	0.17726075583432344	0.20361032764753367	5.672401433691756	-3.209640069203435	NFKB1
KEGG_2021_Human	Necroptosis	1/159	0.18037286671285227	0.20442258227456592	5.562587904360056	-3.1333425612983894	TNFAIP3
KEGG_2021_Human	JAK-STAT signaling pathway	1/162	0.18347437883820783	0.2052016079111535	5.456866804692892	-3.0596637281364782	IL22
KEGG_2021_Human	Tuberculosis	1/180	0.20186266926868635	0.22283541412777064	4.896958410924891	-2.6658400097237527	NFKB1
KEGG_2021_Human	Neutrophil extracellular trap formation	1/189	0.21091631211370437	0.2298446990982676	4.657210401891253	-2.4954112144854435	NFKB1
KEGG_2021_Human	Transcriptional misregulation in cancer	1/192	0.21391358807496763	0.23016018970091454	4.5823152995927865	-2.441961042053517	NFKB1
KEGG_2021_Human	Diabetic cardiomyopathy	1/203	0.22481613944093093	0.2388671481559891	4.326732673267327	-2.2588473265567357	NFKB1
KEGG_2021_Human	cAMP signaling pathway	1/216	0.23752539179620868	0.24925504077379926	4.058397932816537	-2.065502377074288	NFKB1
KEGG_2021_Human	Chemical carcinogenesis	1/239	0.2595523897792453	0.26904820891751036	3.6554621848739495	-1.7734497985532327	NFKB1
KEGG_2021_Human	MicroRNAs in cancer	1/310	0.3239838755949599	0.33179071597074206	2.7900035958288387	-1.143955577607994	NFKB1
KEGG_2021_Human	Alzheimer disease	1/369	0.3736370340305108	0.37808509395944545	2.32487922705314	-0.8103995559567543	NFKB1
KEGG_2021_Human	Pathways of neurodegeneration	1/475	0.45466905008847364	0.45466905008847364	1.7801218940459447	-0.4367315309409891	NFKB1
